Abdul Latif Jameel Health and Wellesta Holdings has announced a new agreement for the marketing and distribution of the Butterfly iQ+ point-of-care ultrasound device in The Republic of India.
The Butterfly iQ+ is the single probe, whole-body handheld point-of-care ultrasound solution. As part of its new agreement with Abdul Latif Jameel Health, Wellesta will register Butterfly iQ+ in India and start promoting and selling the product in the country in the fourth quarter of 2022, bringing this technology to a potential 1.2 million registered physicians in the country.
This new collaboration will offer greater distribution of Butterfly iQ+ to physicians in India thereby expanding the capabilities of the practitioners in making informed decisions thereby accelerating access to modern medical care for those who need it most.
Butterfly iQ+ is a hand-held 4 in 1 single probe whole-body innovative point-of-care ultrasound device powered by Ultrasound–on-Chip technology. This point of care device with over 20 default pre-sets is compatible with both iOS and Android smart devices and comes complete with battery back, wireless charging, cloud storage, customized app., software, and AI support.
It can transform the complex processes, into one connected and integrated point-of-care ultrasound (POCUS) system to help collect advanced imaging, perform rapid assessments, and guide critical procedures and allows the sharing of results seamlessly with doctors across the globe to help read and interpret scans.
